Jump to main content
Jump to site search


Hierarchical nanocomposites of graphene oxide and PEGylated protoporphyrin as carriers to load doxorubicin hydrochloride for trimodal synergistic therapy

Abstract

Multimodal and synergistic therapy of cancer has appeared as one of the most promising strategies in treating cancer. Here, we report a supramolecular hierarchical nanocomposite for combination photodynamic, photothermal, and chemo-therapy. Graphene oxide (GO, photothermal agent for photothermal therapy, PTT), protoporphyrin IX (PpIX, photosensitizer for photodynamic therapy, PDT), and hydrophilic anticancer drug doxorubicin hydrochloride (DOX∙HCl, therapeutic for chemotherapy) are involved in hierarchical self-assembled nanocomposites via supramolecular interactions. PEGylated PpIX (PEG-PpIX) is prepared to improve the stability of GO in physiological conditions. The nanocomposite GO(PEG-PpIX) is non-cytotoxic in dark and phototoxic with light irradiation to exhibit efficient PTT and PDT effects. The drug loading content of the nanocomposite DOX/GO(PEG-PpIX) is as high as 15.9% and the drug release shows a pH-dependent profile. The combined PDT, PTT, and chemotherapy show the excellent in vivo antitumor effect and side effects reduction. This work presents a facile yet robust strategy to fabricate a nanocomposite for multimodal synergistic therapy.

Back to tab navigation

Supplementary files

Publication details

The article was received on 17 Mar 2018, accepted on 11 Jun 2018 and first published on 13 Jun 2018


Article type: Paper
DOI: 10.1039/C8TB00733K
Citation: J. Mater. Chem. B, 2018, Accepted Manuscript
  •   Request permissions

    Hierarchical nanocomposites of graphene oxide and PEGylated protoporphyrin as carriers to load doxorubicin hydrochloride for trimodal synergistic therapy

    T. Su, F. Cheng, J. Yan, J. Cao, K. Luo, Y. Pu and B. He, J. Mater. Chem. B, 2018, Accepted Manuscript , DOI: 10.1039/C8TB00733K

Search articles by author

Spotlight

Advertisements